Company Receives BioNest Grant to Support Entry into US Market CorestemChemon, a biopharmaceutical company headquartered in South Korea, has selected Winston-Salem as the location for its U.S. base of operations. The company will be located within the Regenerative Medicine (RegenMed) Engine’s Innovation Accelerator, based in the Innovation Quarter.  With about 350 employees worldwide, CorestemChemon is … Continue reading Korean Biopharmaceutical Company, CorestemChemon, Selects Winston-Salem’s Wake Forest Institute for Regenerative Medicine (WFIRM) for US Base of Operations